• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Late and chronic antibody-mediated rejection: main barrier to long term graft survival.迟发性和慢性抗体介导的排斥反应:长期移植物存活的主要障碍。
Clin Dev Immunol. 2013;2013:859761. doi: 10.1155/2013/859761. Epub 2013 Oct 8.
2
Maintenance immunosuppressants in the management of antibody-mediated renal allograft rejection: which regimen is best?维持性免疫抑制剂在抗体介导的肾移植排斥反应管理中的应用:哪种方案最佳?
Immunotherapy. 2017 Jan;9(1):47-55. doi: 10.2217/imt-2016-0096.
3
Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.移植前供体特异性抗 HLA 抗体与抗体介导的排斥反应、进行性移植物功能障碍和患者死亡有关。
Transpl Immunol. 2013 Jun;28(4):148-53. doi: 10.1016/j.trim.2013.05.001. Epub 2013 May 9.
4
Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation.抑制预先致敏的移植受者体内的末端补体成分可预防抗体介导的排斥反应,从而实现长期移植存活和免疫适应。
J Immunol. 2007 Oct 1;179(7):4451-63. doi: 10.4049/jimmunol.179.7.4451.
5
Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.肝移植中供者特异性人类白细胞抗原抗体的临床意义
World J Gastroenterol. 2015 Oct 21;21(39):11016-26. doi: 10.3748/wjg.v21.i39.11016.
6
Graft Immunocomplex Capture Fluorescence Analysis to Detect Donor-Specific Antibodies and HLA Antigen Complexes in the Allograft.移植免疫复合物捕获荧光分析以检测同种异体移植物中的供体特异性抗体和HLA抗原复合物
Immunol Invest. 2017 Apr;46(3):295-304. doi: 10.1080/08820139.2016.1258711. Epub 2017 Feb 2.
7
Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study.未能清除新产生的供体特异性 HLA 抗体受抗体特性的影响,并可识别出发生晚期抗体介导排斥反应导致移植物丢失的肾移植受者——一项回顾性研究。
Transpl Int. 2019 Jan;32(1):38-48. doi: 10.1111/tri.13325. Epub 2018 Aug 27.
8
Desensitization for prevention of chronic antibody-mediated rejection after kidney transplantation.肾移植后预防慢性抗体介导排斥反应的脱敏治疗。
Clin Transplant. 2013 Nov-Dec;27 Suppl 26:2-8. doi: 10.1111/ctr.12260.
9
Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.预先形成的补体激活低水平供体特异性抗体可预测肾移植中的早期抗体介导的排斥反应。
Transplantation. 2013 Jan 27;95(2):341-6. doi: 10.1097/TP.0b013e3182743cfa.
10
Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection.并非所有抗体都是平等的:影响抗体介导排斥反应的因素。
J Immunol Res. 2017;2017:7903471. doi: 10.1155/2017/7903471. Epub 2017 Mar 8.

引用本文的文献

1
IL-6/IL-6R Signaling Blockade Alleviates Chronic Allograft Rejection by Modulating Germinal Center B Cells and Allograft Inflammation in Murine Cardiac Transplantation.IL-6/IL-6R信号通路阻断通过调节生发中心B细胞和小鼠心脏移植中的移植物炎症来减轻慢性移植物排斥反应。
J Inflamm Res. 2025 Jul 12;18:9145-9158. doi: 10.2147/JIR.S520034. eCollection 2025.
2
Improving long-term kidney allograft survival by rethinking HLA compatibility: from molecular matching to non-HLA genes.通过重新思考HLA相容性提高肾移植长期存活率:从分子匹配到非HLA基因
Front Genet. 2024 Oct 2;15:1442018. doi: 10.3389/fgene.2024.1442018. eCollection 2024.
3
New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation.器官移植中对供体特异性HLA抗体的适应性血管反应的新见解。
Front Transplant. 2023 Apr 28;2:1146040. doi: 10.3389/frtra.2023.1146040. eCollection 2023.
4
Human cytomegalovirus and Epstein-Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients.人类巨细胞病毒和 Epstein-Barr 病毒感染发生在移植后早期是心脏移植受者抗体介导排斥反应的危险因素。
Front Immunol. 2023 May 15;14:1171197. doi: 10.3389/fimmu.2023.1171197. eCollection 2023.
5
IRF4 ablation in B cells abrogates allogeneic B cell responses and prevents chronic transplant rejection.IRF4 在 B 细胞中的缺失可消除同种异体 B 细胞反应并防止慢性移植排斥。
J Heart Lung Transplant. 2021 Oct;40(10):1122-1132. doi: 10.1016/j.healun.2021.06.008. Epub 2021 Jun 23.
6
Evaluation of Thymic Output and Regulatory T Cells in Kidney Transplant Recipients with Chronic Antibody-Mediated Rejection.评估慢性抗体介导排斥反应的肾移植受者的胸腺输出和调节性 T 细胞。
Biomed Res Int. 2021 Feb 9;2021:6627909. doi: 10.1155/2021/6627909. eCollection 2021.
7
Association between transplant glomerulopathy and graft outcomes following kidney transplantation: A meta-analysis.移植肾小球病与肾移植后移植物结局的关系:一项荟萃分析。
PLoS One. 2020 Apr 28;15(4):e0231646. doi: 10.1371/journal.pone.0231646. eCollection 2020.
8
Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation.预存的针对人类白细胞抗原II类分子的供者特异性抗体与死亡供者肾移植的移植物预后
Transplant Direct. 2019 Apr 15;5(5):e446. doi: 10.1097/TXD.0000000000000893. eCollection 2019 May.
9
mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.mTOR抑制通过直接抑制同种异体预致敏B细胞和保留CD8 +抗体抑制性T细胞来抑制移植后同种异体抗体的产生。
Transplantation. 2016 Sep;100(9):1898-906. doi: 10.1097/TP.0000000000001291.
10
Expanding the antibody-mediated component of plasma cell-rich acute rejection: A case series.扩大富含浆细胞的急性排斥反应中抗体介导的成分:病例系列
Indian J Nephrol. 2016 May-Jun;26(3):176-81. doi: 10.4103/0971-4065.159300.

本文引用的文献

1
Microcirculation lesions alone are not reliable for identifying antibody-mediated rejection.仅靠微循环病变来识别抗体介导的排斥反应并不可靠。
Am J Transplant. 2013 Jul;13(7):1931-2. doi: 10.1111/ajt.12317. Epub 2013 Jun 17.
2
Early versus late acute antibody-mediated rejection in renal transplant recipients.肾移植受者的早期与晚期急性抗体介导的排斥反应。
Transplantation. 2013 Jul 15;96(1):79-84. doi: 10.1097/TP.0b013e31829434d4.
3
A survey of current practice for antibody-mediated rejection in heart transplantation.心脏移植中抗体介导排斥反应的当前实践调查。
Am J Transplant. 2013 Apr;13(4):1069-1074. doi: 10.1111/ajt.12162. Epub 2013 Feb 15.
4
Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.原发性肾移植中供体特异性同种异体抗体的发生率和影响。
Transplantation. 2013 Feb 15;95(3):410-7. doi: 10.1097/TP.0b013e31827d62e3.
5
Pathology of C4d-negative antibody-mediated rejection in renal allografts.肾移植中 C4d 阴性抗体介导排斥反应的病理学。
Curr Opin Organ Transplant. 2013 Jun;18(3):319-26. doi: 10.1097/MOT.0b013e32835d4daf.
6
Case report: Eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant.病例报告:依库珠单抗挽救ABO血型不相容肾移植术后严重加速性抗体介导的排斥反应
Transplant Proc. 2012 Dec;44(10):3033-6. doi: 10.1016/j.transproceed.2012.03.053. Epub 2012 Sep 6.
7
Antibody-mediated vascular rejection of kidney allografts: a population-based study.抗体介导的肾移植血管排斥反应:一项基于人群的研究。
Lancet. 2013 Jan 26;381(9863):313-9. doi: 10.1016/S0140-6736(12)61265-3. Epub 2012 Nov 23.
8
Eculizumab treatment of acute antibody-mediated rejection in renal transplantation: case reports.依库珠单抗治疗肾移植急性抗体介导的排斥反应:病例报告
Transplant Proc. 2012 Nov;44(9):2690-4. doi: 10.1016/j.transproceed.2012.09.038.
9
Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation.从 CAN 中挑出移植性肾小球病:临床病理评估的证据。
BMC Nephrol. 2012 Sep 28;13:128. doi: 10.1186/1471-2369-13-128.
10
Antibody-Mediated Lung Transplant Rejection.抗体介导的肺移植排斥反应
Curr Respir Care Rep. 2012 Sep;1(3):157-161. doi: 10.1007/s13665-012-0019-8.

迟发性和慢性抗体介导的排斥反应:长期移植物存活的主要障碍。

Late and chronic antibody-mediated rejection: main barrier to long term graft survival.

作者信息

Sun Qiquan, Yang Yang

机构信息

Department of Renal Transplantation, The Third Affiliated Hospital, Sun Yat-Sen University, 600 Tianhe Road, Guangzhou 510630, China.

出版信息

Clin Dev Immunol. 2013;2013:859761. doi: 10.1155/2013/859761. Epub 2013 Oct 8.

DOI:10.1155/2013/859761
PMID:24222777
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3816029/
Abstract

Antibody-mediated rejection (AMR) is an important cause of graft loss after organ transplantation. It is caused by anti-donor-specific antibodies especially anti-HLA antibodies. C4d had been regarded as a diagnosis marker for AMR. Although most early AMR episodes can be successfully controlled or reversed, late and chronic AMR remains the leading cause of late graft loss. The strategies which work in early AMR have limited effect on late/chronic episodes. Here, we reviewed the lines of evidence that late/chronic AMR is the leading cause of late graft loss, characteristics of late AMR, and current strategies in managing late/chronic AMR. More effort should be put on the management of late/chronic AMR to make a better long term graft survival.

摘要

抗体介导的排斥反应(AMR)是器官移植后移植物丢失的重要原因。它由抗供体特异性抗体尤其是抗HLA抗体引起。C4d一直被视为AMR的诊断标志物。尽管大多数早期AMR发作可以成功控制或逆转,但晚期和慢性AMR仍然是晚期移植物丢失的主要原因。在早期AMR中有效的策略对晚期/慢性发作的效果有限。在此,我们综述了晚期/慢性AMR是晚期移植物丢失的主要原因的证据、晚期AMR的特征以及当前管理晚期/慢性AMR的策略。应更加努力管理晚期/慢性AMR,以实现更好的长期移植物存活。